EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk factors for severe radiation-induced dermatitis in nasopharyngeal carcinoma patients undergoing radiotherapy

Dong-Xia Liao, Dan Zhao, Feng-Ling Yang, Zhang Li, Xiao-Xue Deng, Zi-Dan Qiu

Frontiers in Oncology · 27.07.2026 · 16

DOI: 10.3389/fonc.2026.1851374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 27.07.2026. Verfasst von Dong-Xia Liao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Radiation-induced dermatitis (RID) is a common toxicity in patients with nasopharyngeal carcinoma (NPC) undergoing radiotherapy. This study aimed to evaluate the incidence, onset time, and factors associated with severe RID in patients with NPC.

Methods

This retrospective study included 287 patients with histologically confirmed NPC who received radiotherapy between August 2020 and August 2025. RID was graded according to the Radiation Therapy Oncology Group (RTOG) acute radiation morbidity criteria. Severe RID was defined as RTOG grade ≥3. Patients were classified into non-severe RID (RTOG grade 0–2) and severe RID groups. Baseline, clinicopathological, treatment-related, and laboratory variables were compared between groups. Logistic regression was used to identify factors associated with severe RID.

Results

Patients were stratified into a non-severe group (RTOG grade 0–2, n = 201) and a severe group (RTOG grade ≥3, n = 86). The mean onset time was 24.8 ± 6.7 days for RTOG grade ≥1 RID and 37.6 ± 6.3 days for RTOG grade ≥3 RID. In multivariable analysis, older age (odds ratio [OR] = 1.03, 95% confidence interval [CI]: 1.01–1.06), smoking history (OR = 1.93, 95% CI: 1.11–3.55), higher total radiation dose (OR = 1.08, 95% CI: 1.01–1.15), elevated C-reactive protein (OR = 1.12, 95% CI: 1.06–1.20), higher neutrophil-to-lymphocyte ratio (OR = 1.53, 95% CI: 1.21–1.96), and larger irradiation area (OR = 1.16, 95% CI: 1.06–1.28) were positively associated with severe RID, whereas higher albumin was inversely associated with severe RID (OR = 0.89, 95% CI: 0.82–0.95).

Conclusions

Severe radiation-induced dermatitis was observed in 30.0% of patients with nasopharyngeal carcinoma receiving radiotherapy. Older age, smoking history, higher radiation dose, elevated inflammatory status, larger irradiation area, and lower albumin level were independently associated with severe radiation-induced dermatitis.

Schlagwörter

Stichwörter der Autor:innen

C-reactive proteinalbuminnasopharyngeal carcinomaneutrophil-to-lymphocyte ratioradiation-induced dermatitisradiotherapyrisk factors

Autor:innen und Institutionen

  • Department of Radiation Oncology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.
  • Department of Oncology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.

Zitieren

APA

Liao, D. X., Zhao, D., Yang, F. L., Li, Z., Deng, X. X., & Qiu, Z. D. (2026). Risk factors for severe radiation-induced dermatitis in nasopharyngeal carcinoma patients undergoing radiotherapy. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1851374

Vancouver

Liao DX, Zhao D, Yang FL, Li Z, Deng XX, Qiu ZD. Risk factors for severe radiation-induced dermatitis in nasopharyngeal carcinoma patients undergoing radiotherapy. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1851374

BibTeX
@article{Liao2026,
  author = {Liao, Dong-Xia and Zhao, Dan and Yang, Feng-Ling and Li, Zhang and Deng, Xiao-Xue and Qiu, Zi-Dan},
  title = {Risk factors for severe radiation-induced dermatitis in nasopharyngeal carcinoma patients undergoing radiotherapy},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1851374}
}
Kostenlos starten →